4//SEC Filing
Blueprint Medicines Corp 4
Accession 0001179110-16-022256
CIK 0001597264operating
Filed
Mar 27, 8:00 PM ET
Accepted
Mar 28, 5:22 PM ET
Size
10.1 KB
Accession
0001179110-16-022256
Insider Transaction Report
Form 4
Lengauer Christoph
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2016-03-24$1.87/sh+6,668$12,469→ 91,382 total - Exercise/Conversion
Stock Option (Right to Buy)
2016-03-24−6,668→ 134,316 totalExercise: $1.87Exp: 2024-08-14→ Common Stock (6,668 underlying) - Exercise/Conversion
Common Stock
2016-03-24$1.49/sh+12,499$18,561→ 84,714 total - Exercise/Conversion
Stock Option (Right to Buy)
2016-03-24−12,499→ 140,984 totalExercise: $1.49Exp: 2023-11-03→ Common Stock (12,499 underlying)
Footnotes (2)
- [F1]This option vests in 48 equal monthly installments beginning on November 1, 2013.
- [F2]This option vests in 48 equal monthly installments beginning on August 18, 2014.
Documents
Issuer
Blueprint Medicines Corp
CIK 0001597264
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001597264
Filing Metadata
- Form type
- 4
- Filed
- Mar 27, 8:00 PM ET
- Accepted
- Mar 28, 5:22 PM ET
- Size
- 10.1 KB